The maraca plot: A novel visualization of hierarchical composite endpoints

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

(2022) Adriaan A. Voors et al.   NATURE MEDICINE

Comments on “Sample size formula for a win ratio endpoint” by R. X. Yu and J. Ganju

(2022) Samvel B. Gasparyan et al.   STATISTICS IN MEDICINE

Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial

(2022) Samvel B. Gasparyan et al.   Therapeutic Innovation & Regulatory Science

Win odds: An adaptation of the win ratio to include ties

(2021) Edgar Brunner et al.   STATISTICS IN MEDICINE

Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials

(2021) Samvel B. Gasparyan et al.   Journal of Biopharmaceutical Statistics

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

(2021) Mikhail N Kosiborod et al.   Lancet Diabetes & Endocrinology

Adjusted win ratio with stratification: Calculation methods and interpretation

(2020) Samvel B Gasparyan et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Graphing the Win Ratio and its components over time

(2018) Dianne M. Finkelstein et al.   STATISTICS IN MEDICINE

Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure

(2016) Milton Packer   CIRCULATION